Filter Results:
(922)
Show Results For
- All HBS Web
(922)
- People (1)
- News (261)
- Research (584)
- Events (1)
- Multimedia (13)
- Faculty Publications (466)
Show Results For
- All HBS Web
(922)
- People (1)
- News (261)
- Research (584)
- Events (1)
- Multimedia (13)
- Faculty Publications (466)
- Awards
Pre-Doctoral Fellowship
By: Josh Lerner
Received a 1989-1991 Pre-Doctoral Fellowship from the Belfer Center for Science and International Affairs at the John F. Kennedy School of Government at Harvard University. View Details
- 14 Oct 2019
- News
Private-equity deals depress worker wages, study finds
- December 2016
- Simulation
Venture Capital and Private Equity Game
By: Matthew Rhodes-Kropf, Josh Lerner, G. Felda Hardymon and Nathaniel Burbank
The Venture Capital and Private Equity Simulation enables groups of students to play the role of either an early or later stage private equity firm. Within the simulation, students raise funds, search for companies to invest in, complete deals, and manage a portfolio... View Details
- Web
Connect with Clubs - Recruiting
Hire Talent Connect with Clubs Hire Talent Connect with Clubs Partner with a HBS Student Club Reach targeted groups of students by connecting with over 50 career-related student clubs. Work with club leaders to sponsor events, advertise... View Details
- May 2001
- Article
The Open Source Movement: Key Research Questions
By: Josh Lerner and Jean Tirole
The paper analyzes the incentives of individual programmers and of commercial companies to participate in open source projects. While these incentives are in our opinion well accounted for by the economic paradigm, much empirical and theoretical work is still needed to... View Details
Lerner, Josh, and Jean Tirole. "The Open Source Movement: Key Research Questions." Special Issue on Papers and Proceedings of the 15th Congress of the European Economic Association European Economic Review 45, nos. 4-6 (May 2001): 819–826.
- October 1992 (Revised November 1997)
- Case
ImmuLogic Pharmaceutical Corporation (A): March 1991
By: Josh Lerner
ImmuLogic Pharmaceutical Corp., a development-stage biotechnology company, is considering making an initial offering of common stock. The diverse perspectives of the entrepreneur, venture capitalist, investment banker, and institutional investor are explored. Problems... View Details
Keywords: Decisions; Entrepreneurship; Venture Capital; Banks and Banking; Initial Public Offering; Going Public; Perspective; Valuation; Biotechnology Industry; Pharmaceutical Industry
Lerner, Josh. "ImmuLogic Pharmaceutical Corporation (A): March 1991." Harvard Business School Case 293-066, October 1992. (Revised November 1997.)
- 29 Jul 2017
- News
Fund managers challenged to confront lack of ethnic diversity
- January 1995
- Background Note
A Note on Distribution of Venture Investments
By: Josh Lerner
Venture capitalists typically exit investments by distributing shares to investors. These transfers pose challenges for these investors. Predictions and evidence about the behavior of stock prices of firms around the time of these distributions are presented. View Details
Lerner, Josh. "A Note on Distribution of Venture Investments." Harvard Business School Background Note 295-095, January 1995.
- May 2009
- Article
The Empirical Impact of Intellectual Property Rights on Innovation: Puzzles and Clues
By: Josh Lerner
Economists have long seen the patent system as a crucial lever through which policymakers affect the speed and nature of innovation in the economy. It is not surprising, then, that the profound changes which have roiled the global patent system over the past 20 years... View Details
Keywords: Economy; Policy; Innovation and Invention; Intellectual Property; Rights; Business and Government Relations
Lerner, Josh. "The Empirical Impact of Intellectual Property Rights on Innovation: Puzzles and Clues." American Economic Review: Papers and Proceedings 99, no. 2 (May 2009): 343–348. (Earlier version distributed as National Bureau of Economic Research Working Paper No. 8977.)
- Web
Finance - Faculty & Research
Velayudhan. "Fiscal Externalities of Transaction Taxes: Evidence from the Los Angeles Mansion Tax." SSRN Working Paper Series, No. 5273034, June 2025. More Publications Faculty Josh Lerner Paul A. Gompers... View Details
- Web
Strategy Curriculum - Faculty & Research
and how to sustain competitive advantage. How to generate superior value for customers by designing the optimum configuration of the product mix and functional activities. How to balance the opportunities and risks associated with dynamic... View Details
- February 2006 (Revised January 2007)
- Case
ABRY Partners, LLC: WideOpenWest
By: Josh Lerner and Smart Darren
ABRY, a Boston-based private equity group, is considering whether to terminate its investment in WideOpenWest or to try to salvage the transaction by acquiring a division of telecommunications unit Ameritech. View Details
Keywords: Private Equity; Investment Portfolio; Problems and Challenges; Financial Services Industry; Media and Broadcasting Industry; Boston
Lerner, Josh, and Smart Darren. "ABRY Partners, LLC: WideOpenWest." Harvard Business School Case 806-116, February 2006. (Revised January 2007.)
- Web
2023 Reunion Presentations - Alumni
key to their success allows us to understand what legacy brands should be doing differently. Participants left the session with an understanding of the challenges facing legacy brands and what to do about it. The Venture Capital "Big Bang" and Its Aftermath: Death Star... View Details
- December 1992 (Revised September 1996)
- Case
ImmuLogic Pharmaceutical Corporation (Abridged)
By: Josh Lerner
ImmuLogic Pharmaceutical Corp., a development-stage biotechnology company, is considering making an initial offering of common stock. The rationales for and problems of high-technology start-ups are explored. The challenges posed by "windows" for public offerings are... View Details
Keywords: Decisions; Initial Public Offering; Entrepreneurship; Going Public; Business Startups; Biotechnology Industry; Pharmaceutical Industry; United States
Lerner, Josh. "ImmuLogic Pharmaceutical Corporation (Abridged)." Harvard Business School Case 293-087, December 1992. (Revised September 1996.)
- 2009
- Working Paper
Private Equity and Industry Performance
By: Josh Lerner
The growth of the private equity industry has spurred concerns about its potential impact on the economy more generally. This analysis looks across nations and industries to assess the impact of private equity on industry performance. Industries where PE funds have... View Details
Keywords: Private Equity; Investment; Common Law; Industry Growth; Performance Productivity; Europe; United Kingdom; United States
Lerner, Josh. "Private Equity and Industry Performance." Harvard Business School Working Paper, No. 10-045, December 2009. (NBER Working Paper Series, No. 14861, April 2009.)
- Web
Student Research - Doctoral
Rembrand M. Koning Entrepreneurial Management 1 results Karim R. Lakhani Technology and Operations Management 2 results Jacqueline Ng Lane Technology and Operations Management 2 results Josh Lerner... View Details
- 10 Sep 2013
- News
How Corporate Venture Capital Helps Firms Explore New Territory
- January 1995 (Revised November 1995)
- Case
Candela Laser vs. Cynosure, Inc.
By: Josh Lerner and Benjamin Conway
Summarizes the lawsuit by Candela Laser against its former CEO and founder, who has begun a competing firm. The extent of patent and trade secret protection are crucial issues. View Details
Lerner, Josh, and Benjamin Conway. "Candela Laser vs. Cynosure, Inc." Harvard Business School Case 295-097, January 1995. (Revised November 1995.)
- January 2017 (Revised March 2017)
- Case
SIN Capital and the Fullerton Health IPO
By: Josh Lerner and Ann Leamon
In early 2016, David Sin, founder of the Singapore-based private equity group SIN Capital and chairman of its primary holding, Fullerton Health, was deeply involved in preparations for taking Fullerton public on the Singapore stock exchange. Three years after SIN... View Details
Keywords: Healthcare; Asia; IPO; Financing; Singapore; Growth; Health Care and Treatment; Private Equity; Initial Public Offering; Financing and Loans; Strategy; Value Creation; Growth and Development Strategy; Health Industry; Singapore
Lerner, Josh, and Ann Leamon. "SIN Capital and the Fullerton Health IPO." Harvard Business School Case 817-030, January 2017. (Revised March 2017.)
- September 1995 (Revised May 1998)
- Case
RogersCasey Alternative Investments: Innovative Response to the Distribution Challenge
By: Josh Lerner
RogersCasey Alternative Investments faces the challenge of managing distributions of stock by the private equity investors in which their clients have invested. These distributed shares appear to behave in complex ways, apparently at odds with market efficiency. A... View Details
Keywords: Private Equity; Stocks; Financial Strategy; Investment; Innovation Strategy; Management; Distribution; Performance; Behavior
Lerner, Josh. "RogersCasey Alternative Investments: Innovative Response to the Distribution Challenge." Harvard Business School Case 296-024, September 1995. (Revised May 1998.)